The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.

With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...

Weight loss from Eli Lilly’s Zepbound drug can reportedly be reversed if users stop treatment, according to a new study. In a study published in the journal JAMA, patients on the drug who struggled ...

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new ...

Zepbound (tirzepatide) is a brand-name injection prescribed for weight loss, weight management, and more. You may need to take Zepbound for several months to see the full effects of the drug for ...

Zepbound may lead to more weight loss than Wegovy, with participants losing 20.2% of their body weight in a clinical trial. Participants on Zepbound had a greater decrease in waist size, losing an ...